Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SUTIMLIMAB Cause Haemolysis? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Haemolysis have been filed in association with SUTIMLIMAB (Enjaymo). This represents 17.9% of all adverse event reports for SUTIMLIMAB.

5
Reports of Haemolysis with SUTIMLIMAB
17.9%
of all SUTIMLIMAB reports
0
Deaths
2
Hospitalizations

How Dangerous Is Haemolysis From SUTIMLIMAB?

Of the 5 reports, 2 (40.0%) required hospitalization.

Is Haemolysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SUTIMLIMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does SUTIMLIMAB Cause?

What Other Drugs Cause Haemolysis?

ECULIZUMAB (1,476) HUMAN IMMUNOGLOBULIN G (357) RITUXIMAB (261) RAVULIZUMAB-CWVZ (242) PREDNISONE (192) CYCLOSPORINE (173) DEXAMETHASONE (167) ACETAMINOPHEN (134) VINCRISTINE (132) TACROLIMUS (116)

Related Pages

SUTIMLIMAB Full Profile All Haemolysis Reports All Drugs Causing Haemolysis SUTIMLIMAB Demographics